Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C6H12O7 |
Molecular Weight | 196.1553 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O
InChI
InChIKey=RGHNJXZEOKUKBD-SQOUGZDYSA-N
InChI=1S/C6H12O7/c7-1-2(8)3(9)4(10)5(11)6(12)13/h2-5,7-11H,1H2,(H,12,13)/t2-,3-,4+,5-/m1/s1
Molecular Formula | C6H12O7 |
Molecular Weight | 196.1553 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Sodium ferric gluconate complex (brand name Ferrlecit by Sanofi) is an intravenously administered iron product. Ferrlecit is an iron complex. It works by providing the body with its necessary level of iron. Ferric gluconate has been shown to be effective in dialysis
and non-dialysis associated anemia of chronic kidney
disease (CKD). It has also been shown to be effective in
improving responses to EPO in chemotherapy induced
anemia.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P02792|||Q9BTZ8 Gene ID: 2512.0 Gene Symbol: FTL Target Organism: Homo sapiens (Human) Sources: https://www.drugbank.ca/drugs/DB09517 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Ferrlecit Approved UseFerrlecit is indicated for the treatment of iron deficiency anemia in adult patients and in pediatric patients age 6 years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy. Launch Date9.1929602E11 |
|||
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
12.9 μg/mL |
1.5 mg/kg single, intravenous dose: 1.5 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered: |
GLUCONATE ION plasma | Homo sapiens population: UNHEALTHY age: CHILD sex: FEMALE / MALE food status: UNKNOWN |
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
95 μg × h/mL |
1.5 mg/kg single, intravenous dose: 1.5 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered: |
GLUCONATE ION plasma | Homo sapiens population: UNHEALTHY age: CHILD sex: FEMALE / MALE food status: UNKNOWN |
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
2 h |
1.5 mg/kg single, intravenous dose: 1.5 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered: |
GLUCONATE ION plasma | Homo sapiens population: UNHEALTHY age: CHILD sex: FEMALE / MALE food status: UNKNOWN |
PubMed
Title | Date | PubMed |
---|---|---|
Clinical features, tissue smear and competitive enzyme linked immunosorbent assay as dignostic and prognostic procedures for visceral leishmaniasis in Yemen. | 2001 Aug |
|
Post-natal ontogeny of stanniocalcin gene expression in rodent kidney and regulation by dietary calcium and phosphate. | 2001 Dec |
|
Iron sucrose or ferric gluconate? | 2001 Dec |
|
Cryptdin-3 induces novel apical conductance(s) in Cl- secretory, including cystic fibrosis, epithelia. | 2001 Feb |
|
Amount of elemental calcium in calcium solutions. | 2001 Feb |
|
GpdA-promoter-controlled production of glucose oxidase by recombinant Aspergillus niger using nonglucose carbon sources. | 2001 Jan |
|
Inhibitors of the Cl-/HCO3- exchanger activate an anion channel with similar features in the epithelial cells of rabbit gallbladder: patch-clamp analysis. | 2001 Jan |
|
Azospirillum doebereinerae sp. nov., a nitrogen-fixing bacterium associated with the C4-grass Miscanthus. | 2001 Jan |
|
Method development and validation for the determination of various sulfur-containing anions and other anions in the corrosion process by capillary ion electrophoresis with indirect detection. | 2001 Jan |
|
Usefulness of the combination of pre- and intraoperative selective intraarterial calcium injection to detect residual insulinomas. | 2001 Jan |
|
Identification of a new class of biopolymer: bacterial synthesis of a sulfur-containing polymer with thioester linkages. | 2001 Jan |
|
Effects of naloxone on calcium turnover in cows affected by milk fever. | 2001 Jul |
|
Apical membrane of native OMCD(i) cells has nonselective cation channels. | 2001 Jul |
|
Primary hypoparathyroidism in a cat complicated by suspect iatrogenic calcinosis cutis. | 2001 Jul-Aug |
|
Sugar-free zinc gluconate glycine lozenges (Cold-Eeze) do not adversely affect glucose control in patients with type 1 or type 2 diabetes mellitus. | 2001 Jul-Aug |
|
Hypocalcaemia and hypomagnesaemia due to hydrofluoric acid. | 2001 Jun |
|
Heterologous expression of the acyl-acyl carrier protein thioesterase gene from the plant Umbellularia californica mediates polyhydroxyalkanoate biosynthesis in recombinant Escherichia coli. | 2001 Mar |
|
Calcium L-edge XANES study of some calcium compounds. | 2001 Mar 1 |
|
Variation of enzyme activities at a branched pathway involved in the utilization of gluconate in Escherichia coli. | 2001 May |
|
Bursting activity in leech Retzius neurons induced by low external chloride. | 2001 May |
|
Lymph osmolality and rehydration from NaCl solutions by toads, Bufo marinus. | 2001 May |
|
Calcinosis cutis as a complication of parenteral calcium gluconate therapy. | 2001 May |
|
Role of CFTR's PDZ1-binding domain, NBF1 and Cl(-) conductance in inhibition of epithelial Na(+) channels in Xenopus oocytes. | 2001 Nov 1 |
|
An atypical chemical burn. | 2001 Nov 3 |
|
99mTc-labeling experiments on CCK(4) by a direct method. | 2001 Oct |
|
Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients. | 2001 Oct |
|
[Possible treatments of glottic spasm]. | 2001 Sep |
|
Novel degradable polymers combining D-gluconic acid, a sugar of vegetal origin, with lactic and glycolic acids. | 2001 Winter |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:19:17 UTC 2023
by
admin
on
Fri Dec 15 15:19:17 UTC 2023
|
Record UNII |
R4R8J0Q44B
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
1108 (Number of products:5)
Created by
admin on Fri Dec 15 15:19:18 UTC 2023 , Edited by admin on Fri Dec 15 15:19:18 UTC 2023
|
||
|
EPA PESTICIDE CODE |
104
Created by
admin on Fri Dec 15 15:19:18 UTC 2023 , Edited by admin on Fri Dec 15 15:19:18 UTC 2023
|
||
|
JECFA EVALUATION |
INS-574
Created by
admin on Fri Dec 15 15:19:18 UTC 2023 , Edited by admin on Fri Dec 15 15:19:18 UTC 2023
|
||
|
NCI_THESAURUS |
C360
Created by
admin on Fri Dec 15 15:19:18 UTC 2023 , Edited by admin on Fri Dec 15 15:19:18 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
33198
Created by
admin on Fri Dec 15 15:19:18 UTC 2023 , Edited by admin on Fri Dec 15 15:19:18 UTC 2023
|
PRIMARY | |||
|
SUB13980MIG
Created by
admin on Fri Dec 15 15:19:18 UTC 2023 , Edited by admin on Fri Dec 15 15:19:18 UTC 2023
|
PRIMARY | |||
|
DB13180
Created by
admin on Fri Dec 15 15:19:18 UTC 2023 , Edited by admin on Fri Dec 15 15:19:18 UTC 2023
|
PRIMARY | |||
|
526-95-4
Created by
admin on Fri Dec 15 15:19:18 UTC 2023 , Edited by admin on Fri Dec 15 15:19:18 UTC 2023
|
PRIMARY | |||
|
487
Created by
admin on Fri Dec 15 15:19:18 UTC 2023 , Edited by admin on Fri Dec 15 15:19:18 UTC 2023
|
PRIMARY | |||
|
3264
Created by
admin on Fri Dec 15 15:19:18 UTC 2023 , Edited by admin on Fri Dec 15 15:19:18 UTC 2023
|
PRIMARY | |||
|
R4R8J0Q44B
Created by
admin on Fri Dec 15 15:19:18 UTC 2023 , Edited by admin on Fri Dec 15 15:19:18 UTC 2023
|
PRIMARY | |||
|
2475956
Created by
admin on Fri Dec 15 15:19:18 UTC 2023 , Edited by admin on Fri Dec 15 15:19:18 UTC 2023
|
PRIMARY | |||
|
C61777
Created by
admin on Fri Dec 15 15:19:18 UTC 2023 , Edited by admin on Fri Dec 15 15:19:18 UTC 2023
|
PRIMARY | |||
|
m5762
Created by
admin on Fri Dec 15 15:19:18 UTC 2023 , Edited by admin on Fri Dec 15 15:19:18 UTC 2023
|
PRIMARY | Merck Index | ||
|
R4R8J0Q44B
Created by
admin on Fri Dec 15 15:19:18 UTC 2023 , Edited by admin on Fri Dec 15 15:19:18 UTC 2023
|
PRIMARY | |||
|
100000078190
Created by
admin on Fri Dec 15 15:19:18 UTC 2023 , Edited by admin on Fri Dec 15 15:19:18 UTC 2023
|
PRIMARY | |||
|
77381
Created by
admin on Fri Dec 15 15:19:18 UTC 2023 , Edited by admin on Fri Dec 15 15:19:18 UTC 2023
|
PRIMARY | |||
|
DTXSID8027169
Created by
admin on Fri Dec 15 15:19:18 UTC 2023 , Edited by admin on Fri Dec 15 15:19:18 UTC 2023
|
PRIMARY | |||
|
10690
Created by
admin on Fri Dec 15 15:19:18 UTC 2023 , Edited by admin on Fri Dec 15 15:19:18 UTC 2023
|
PRIMARY | |||
|
GLUCONIC ACID
Created by
admin on Fri Dec 15 15:19:18 UTC 2023 , Edited by admin on Fri Dec 15 15:19:18 UTC 2023
|
PRIMARY | |||
|
208-401-4
Created by
admin on Fri Dec 15 15:19:18 UTC 2023 , Edited by admin on Fri Dec 15 15:19:18 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |